English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51887221    Online Users :  782
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"liu c h"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 721-745 of 1570  (63 Page(s) Totally)
<< < 24 25 26 27 28 29 30 31 32 33 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-03-09T01:47:40Z Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously Cheng H.-R.; Kao J.-H.; Wu H.-L.; Chen T.-C.; Tseng T.-C.; Liu C.-H.; TUNG-HUNG SU; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏 2021-03-09T01:47:40Z Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications Wu H.-L.; Kao J.-H.; Chen T.-C.; Wu W.-H.; Liu C.-H.; TUNG-HUNG SU; Yang H.-C.; Chen D.-S.; Chen P.-J.; Liu C.-J.
臺大學術典藏 2021-03-09T01:47:39Z Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection Cheng H.-R.; Kao J.-H.; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; TUNG-HUNG SU; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏 2021-03-09T01:47:38Z Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B Lin C.-L.; Liu C.-H.; Wang C.-C.; Liang C.-C.; TUNG-HUNG SU; Liu C.-J.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:37Z Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition TUNG-HUNG SU; Shiau C.-W.; Jao P.; Liu C.-H.; Liu C.-J.; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-03-09T01:47:37Z Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:37Z Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang W.-T.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:37Z Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy Liang C.-C.; Liu C.-H.; Chung C.-S.; Lin C.-K.; TUNG-HUNG SU; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:36Z Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏 2021-03-09T01:47:35Z Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:35Z Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏 2021-03-09T01:47:35Z Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers Tseng T.-C.; Liu C.-J.; Yang H.-C.; Chen C.-L.; Yang W.-T.; Tsai C.-S.; Kuo S.F.-T.; Verbree F.C.; TUNG-HUNG SU; Wang C.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:34Z Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:34Z Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study TUNG-HUNG SU; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:33Z Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection Yang W.-T.; Wu L.-W.; Tseng T.-C.; Chen C.-L.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:25Z Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection Liu C.-H.; Liu C.-J.; TUNG-HUNG SU; Fang Y.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:25Z Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma Tseng T.-C.; Liu C.-J.; TUNG-HUNG SU; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:24Z Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:24Z A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients Liu C.-H.; Liu C.-J.; Hong C.-M.; TUNG-HUNG SU; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; Kao J.-H.; Chen D.-S.; Chen P.-J.
臺大學術典藏 2021-03-09T01:43:24Z Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis TUNG-HUNG SU; Shiau C.-W.; Jao P.; Yang N.-J.; Tai W.-T.; Liu C.-J.; Tseng T.-C.; Yang H.-C.; Liu C.-H.; Huang K.-W.; Hu T.-C.; Huang Y.-J.; Wu Y.-M.; Chen L.-J.; Chen P.-J.; Chen D.-S.; Chen K.-F.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:23Z Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan Liu C.-H.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:22Z Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy TUNG-HUNG SU; Yang H.-C.; Tseng T.-C.; Liou J.-M.; Liu C.-H.; Chen C.-L.; Chen P.-J.; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:21Z Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy TUNG-HUNG SU; Liao C.-H.; Liu C.-H.; Huang K.-W.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:21Z Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection Tseng T.-C.; Liu C.-J.; TUNG-HUNG SU; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:21Z Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection Liu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.

Showing items 721-745 of 1570  (63 Page(s) Totally)
<< < 24 25 26 27 28 29 30 31 32 33 > >>
View [10|25|50] records per page